COVACEUSZACH, SONIA
 Distribuzione geografica
Continente #
AS - Asia 1.596
NA - Nord America 1.269
EU - Europa 370
SA - Sud America 335
Continente sconosciuto - Info sul continente non disponibili 88
AF - Africa 33
OC - Oceania 1
Totale 3.692
Nazione #
US - Stati Uniti d'America 1.191
SG - Singapore 650
CN - Cina 376
BR - Brasile 247
HK - Hong Kong 167
VN - Vietnam 159
IT - Italia 108
FR - Francia 83
KR - Corea 76
NL - Olanda 61
BD - Bangladesh 44
AR - Argentina 35
CA - Canada 31
GB - Regno Unito 28
IN - India 27
JP - Giappone 21
EC - Ecuador 20
DE - Germania 17
FI - Finlandia 16
MX - Messico 14
ZA - Sudafrica 13
CO - Colombia 12
ID - Indonesia 12
TR - Turchia 12
IL - Israele 11
CL - Cile 7
ES - Italia 7
PL - Polonia 7
VE - Venezuela 7
AT - Austria 6
IQ - Iraq 6
MA - Marocco 6
PK - Pakistan 6
UA - Ucraina 6
TH - Thailandia 5
EE - Estonia 4
EG - Egitto 4
HN - Honduras 4
JM - Giamaica 4
PH - Filippine 4
RU - Federazione Russa 4
SE - Svezia 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
KZ - Kazakistan 3
MY - Malesia 3
NI - Nicaragua 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
KN - Saint Kitts e Nevis 2
PR - Porto Rico 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
UY - Uruguay 2
AL - Albania 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MQ - Martinica 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.604
Città #
Singapore 379
Santa Clara 255
Hefei 183
Dallas 176
Hong Kong 164
Ashburn 113
San Jose 109
Beijing 77
Seoul 76
Ho Chi Minh City 69
Lauterbourg 65
Los Angeles 53
Hanoi 40
Amsterdam 27
São Paulo 24
New York 20
Trieste 15
Milan 14
Rio de Janeiro 12
Brasília 11
Tokyo 11
Buffalo 10
Lappeenranta 10
Rome 10
Bengaluru 9
Houston 9
Minamishinagawa 9
Council Bluffs 8
Orem 8
Quito 8
Brooklyn 7
Curitiba 7
Frankfurt am Main 7
Guayaquil 7
Johannesburg 7
Atlanta 6
Bogotá 6
Dhaka 6
Helsinki 6
London 6
Porto Alegre 6
Biên Hòa 5
Buenos Aires 5
Chennai 5
Denver 5
Haiphong 5
Montreal 5
Sorocaba 5
Warsaw 5
Da Nang 4
Las Vegas 4
Manchester 4
Newark 4
Nuremberg 4
Philadelphia 4
Portsmouth 4
Santiago 4
Stockholm 4
Vienna 4
Atibaia 3
Bangkok 3
Belo Horizonte 3
Boardman 3
Campinas 3
Caracas 3
Charlotte 3
Chicago 3
Cincinnati 3
Cleveland 3
Fortaleza 3
Groningen 3
Istanbul 3
Lahore 3
Managua 3
Manila 3
Mexico City 3
Naples 3
Newnan 3
Palermo 3
Panama City 3
Piscataway 3
Queens 3
Quilmes 3
San Antonio 3
San Francisco 3
São Bernardo do Campo 3
Tallinn 3
The Bronx 3
Toronto 3
Acalanes Ridge 2
Albuquerque 2
Arapiraca 2
Athens 2
Baghdad 2
Baltimore 2
Bari 2
Barranquilla 2
Basseterre 2
Bergamo 2
Brampton 2
Totale 2.237
Nome #
Unveiling the Solvent Effect: DMSO Interaction with Human Nerve Growth Factor and Its Implications for Drug Discovery 256
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 118
LuxR Solos in the Plant Endophyte Kosakonia sp. Strain KO348 101
Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody 85
Covalent immobilization of delipidated human serum albumin on poly(pyrrole-2-carboxylic) acid film for the impedimetric detection of perfluorooctanoic acid 77
Distinct conformational changes occur within the intrinsically unstructured pro-domain of pro-Nerve Growth Factor in the presence of ATP and Mg2+ 75
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria 74
X-Ray Diffraction @ Elettra Synchrotron: Atomic Insight Of Your Biomedical Target. 74
ATP binding to the Nerve Growth Factor: a molecular switch for neurotrophins signaling? 72
The binding of ATP to the Nerve Growth Factor: a new mechanism for neurotrophins signaling. 68
Do fats matter? Design of serum albumin bioreceptor for PFOA, from toxicological studies to biosensor applications 67
A Spectroscopic Study on the Amyloid‐β Interaction with Clicked Peptide‐Porphyrin Conjugates: a Vision Toward the Detection of Aβ Peptides in Aqueous Solution 67
Structural determinants for the molecular promiscuity of mouse proNGF 62
Molecular and structural basis of dystroglycanopathies 62
Endogenous modulators of neurotrophin signaling: Landscape of the transient ATP-NGF interactions 62
Axe7A: A novel CE7 Acetylxylan esterase found in rumen bacterium Prevotella ruminicola 23. 61
A primary dystroglycanopathy causing muscle-eye-brain disease with multicystic leukodystrophy: from cellular and biochemical analysis to a mouse model 60
Structural and functional properties of mouse proNGF 59
A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. 59
Structural flexibility of human ?lpha-dystroglycan 58
A combined evolutionary and structural approach to disclose the primary structural determinants essential for proneurotrophins biological functions 58
Synchrotron Radiation as a tool for the investigation of the structural basis of primary dystroglycanopathies. 58
Unveiling the binding mode of perfluorooctanoic acid to human serum albumin 57
LuxR Solos from Environmental Fluorescent Pseudomonads 57
Untangling the Conformational Plasticity of V66M Human proBDNF Polymorphism as a Modifier of Psychiatric Disorder Susceptibility 56
Molecular architecture of the glycogen- committed PP1/PTG holoenzyme. 55
The NGF R100W Mutation, Associated with Hereditary Sensory Autonomic Neuropathy Type V, Specifically Affects the Binding Energetic Landscapes of NGF and of Its Precursor proNGF and p75NTR 55
Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis 52
In vitro receptor binding properties of a painless NGF mutein, linked to Hereditary Sensory Autonomic Neuropathy type V 52
Selection of Natural Compounds with HMGA-Interfering Activities and Cancer Cell Cytotoxicity 51
Structural flexibility of human alpha-dystroglycan 51
Axe7A: A Novel CE7 Acetylxylan Esterase for Biomass Degradation. 51
The molecular basis of alpha-Dystroglycan hypoglycosylation: a crystallographic and SAXS study 51
The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of ?-dystroglycan 50
Quorum sensing signaling studies in Pseudomonas syringae pv. actinidae 47
Negative Regulation of Violacein Biosynthesis in Chromobacterium violaceum 45
The Conundrum of the High-Affinity NGF Binding Site Formation Unveiled? 45
Towards a comprehension of the structure of mouse proNGF 43
Insights into the Nerve Growth Factor / endogenous ligands binding mechanism. 43
Purification, crystallization and preliminary X-ray analysis of the Fab fragment from MNAC13, a novel antagonistic anti- 41
Unraveling the binding mode of the neutralizing neuroantibody aD11 to NGF 41
Enzymatic systems with some potentials in biocatalysis 40
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 38
Identification of a new small Rho GTPase inhibitor effective in glioblastoma human cells 38
Intrinsic structural disorder of mouse proNGF 38
Conformational rigidity within plasticity promotes differential target recognition of Nerve Growth Factor 38
Intrinsic structural disorder of mouse proNGF 37
The molecular basis of alpha-dystroglycan hypoglycosylation: a crystallographic and SAXS study 37
The structure of the T190M mutant of murine ?-dystroglycan at high resolution: insight into the molecular basis of a primary dystroglycanopathy 36
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 35
The molecular basis of ?-dystroglycan hypoglycosylation: a crystallographic and SAXS study 35
Taking Pain Out of NGF: A "Painless" NGF Mutant, Linked to Hereditary Sensory Autonomic Neuropathy Type V, with Full Neurotrophic Activity 34
Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody 34
Purification, crystallization, X-ray diffraction analysis and phasing of a Fab fragment of monoclonal neuroantibody alphaD11 against nerve growth factor. 33
METHOD FOR THE HUMANIZATION OF ANTIBODIES AND HUMANIZED ANTIBODIES THEREBY OBTAINED 33
The Kiwifruit Emerging Pathogen Pseudomonas syringae pv. actinidiae Does Not Produce AHLs but Possesses Three LuxR Solos 33
The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. 33
Towards an understanding of the structure and dynamic of mouse proNGF 33
Insights into the structure and function of mouse proNGF 32
Novel recombinant antibodies against AD biomarkers linked to neurotrophin signalling as potential diagnostic tools 32
Insights into the structure of the N-terminal region of ?-dystroglycan: a concerted crystallographic and SAXS study 32
Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: A structural insight. 32
Functional and structural study of the dimeric inner membrane protein SbmA 32
Live cell optical super-resolution microscopy of dystroglycan mutants as a model for dystroglycanopathies in multiple cell lines 31
Insights into the structure of the N-terminal region of alpha-dystroglycan: a concerted crystallographic and SAXS study 30
Structural and functional properties of mouse proNGF 29
A humanized anti-NGF antibody with analgesic properties 29
Structural basis for the selectivity of recombinant mouse short proNGF versus NGF towards its binding partners. 29
Structural Insights into a Novel Interkingdom Signaling Circuit by Cartography of the Ligand-Binding Sites of the Homologous QuorumSensing LuxR-Family 28
Studies on synthetic LuxR solo hybrids 28
Remarkable analgesic effects of an anti-NGF monoclonal antibody with function neutralizing properties 26
Humanization of therapeutic neutralizing antibodies with analgesic effects 21
Totale 3.692
Categoria #
all - tutte 11.834
article - articoli 7.258
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20244 0 0 0 0 0 0 0 0 1 0 3 0
2024/20251.080 1 19 87 38 213 80 9 79 42 42 252 218
2025/20262.124 113 260 403 305 332 113 238 69 67 102 65 57
2026/2027484 150 84 250 0 0 0 0 0 0 0 0 0
Totale 3.692